Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19-Reference-Cited by-同舟云学术

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

Published:2020-05-30 Issue:1 Volume:19 Page:
ISSN:1476-0711
Container-title:Annals of Clinical Microbiology and Antimicrobials
language:en
Short-container-title:Ann Clin Microbiol Antimicrob

Author:

Sharun Khan,Dhama Kuldeep,Patel Shailesh Kumar,Pathak Mamta,Tiwari Ruchi,Singh Bhoj Raj,Sah Ranjit,Bonilla-Aldana D. Katterine,Rodriguez-Morales Alfonso J.,Leblebicioglu Hakan

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1186/s12941-020-00368-w.pdf

Reference25 articles.

1. Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020. https://doi.org/10.1016/j.antiviral.2020.104787.

2. Campbell WC, Benz GW. Ivermectin: a review of efficacy and safety. J Vet Pharmacol Ther. 1984;7(1):1–16.

3. Crump A, Omura S. Ivermectin, ‘wonderdrug’ from Japan: the human use perspective. Proceed Japan Acad Series B. 2011;87(2):13–28.

4. Sharun K, Shyamkumar TS, Aneesha VA, Dhama K, Pawde AM, Pal A. Current therapeutic applications and pharmacokinetic modulations of ivermectin. Vet World. 2019;12(8):1204–11. https://doi.org/10.14202/vetworld.2019.1204-1211.

5. Rang HP, Dale MM, Ritter JM, Flower RJ, editors. Rang and Dale’s Pharmacology. 6th ed. China: Churchill Livingstone; 2007. p. 715–6.

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity;Heliyon;2024-08

2. In Silico Comparative Analysis of Ivermectin and Nirmatrelvir Inhibitors Interacting with the SARS-CoV-2 Main Protease;Biomolecules;2024-06-25

3. Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 Infection;2024-05-23

4. Ivermectin ameliorates acute myocarditis via the inhibition of importin-mediated nuclear translocation of NF-κB/p65;International Immunopharmacology;2024-05

5. Insights on Various Antiviral Drugs for Treating Patients with COVID-19;Livestock Diseases and Management;2024